Jakarta, CNBC Indonesia – The Russian-made Covid-19 vaccine, Sputnik V, is claimed to provide protection against the Delta variant that is currently spreading. Reportedly this type of vaccine can offer protection of up to more than 90%.
According to the Head of the Novosibirsk State University Laboratory and a member of the Russian Academy of Sciences, Sergey Netesov, the Covid-19 vaccine with a vector and mRNA platform can provide sufficient protection for the variant that has entered Indonesia.
“According to data from the UK, US and other countries, mRNA and vector vaccines including our Sputnik V, protect against (Delta variant), although to a lesser extent, they do protect against it. They offer 95% protection in the initial strain and now provide 90 percent protection. % against the Delta variant,” said Sergey, quoted by the Hindustan Times, Wednesday (14/7/2021).
Previously, there were claims that Sputnik guaranteed almost 100% protection for severe and fatal cases of Covid-19 caused by the Delta variant. This was conveyed by the Head of the Laboratory of the Mechanism of Population Variability of the Gamaleya Research Center that developed Sputnik V, Vladimir Gushchin.
Previously from a trial published in the media journal The Lancet, this vaccine had 91.6% efficacy. Meanwhile, the Gamaleya National Center for Research on Epidemiologists and Microbiology and the Russian Direct Investment Fund reported that Sputnik V had an efficacy of 97.6%.
For information, Russia registered Sputnik V and was the first to release a vaccine against the coronavirus in August 2020.
This vaccine uses two different engineered adenoviruses namely rAd26 and rAd5 in the first and second doses. This is to transmit the genetic code for the viral spike protein into the recipient’s body.
Developers in Russia aim to improve the vaccine’s efficacy by choosing two different delivery mechanisms rather than just one engineered adenovirus like those in AstraZeneca and Johnson&Johnson.
For side effects, there are no reports of blood clots in Sputnik V recipients. Currently the vaccine is used by Russian health authorities as well as more than 60 countries around the world.
Sputnik V will also be used in Indonesia. According to the Head of the POM Agency, Penny Lukito, the vaccine is in the process of obtaining an emergency use authorization (EUA) in Indonesia.
According to him, inspections of production facilities must be carried out and there is no experience with vaccines from Russia. “We are in the process of finalizing some inspection coverage data. Hopefully Sputnik will get the EUA,” said Penny during a Working Meeting with Commission IX of the Indonesian House of Representatives, Tuesday (13/7/2021).
(roy/roy)
– .
